EUVIMEDEUVIMED entdecken
Open Access

Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design

Ashwin N Skelly iD, Harry B Gristick iD, Hui Li iD, Edem Gavor iD, Andrew J Connell iD, Edward F Kreider iD, Lorie Marchitto iD, Michael P Hogarty iD, Maddy L Newby iD, Joel D Allen iD, Weimin Liu iD, Anthony P West iD und 46 weitere

Science · 18.06.2026 · 392 (6804)

DOI: 10.1126/science.aec6396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 18.06.2026. Verfasst von Ashwin N Skelly und 57 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: AIDS Vaccines, Broadly Neutralizing Antibodies, env Gene Products, Human Immunodeficiency Virus, HIV Antibodies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Bill & Melinda Gates Foundation, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major obstacle confronting HIV-1 vaccine and cure research is the lack of an outbred animal model for rapid and consistent induction of broadly neutralizing antibodies (bNAbs). We designed an epitope-focused simian-human immunodeficiency virus (SHIV.5MUT) that elicited broad and potent V3-glycan–targeted antibodies within a year of infection in 14 of 22 macaques compared with 0 of 14 control animals. SHIV.5MUT elicited bNAbs by a two-step mechanism, inducing an initial wave of V1-directed antibodies that selected for envelope (Env) glycoprotein variants with shortened, hypoglycosylated V1 loops, which in turn primed V3-glycan bNAb precursors. Rhesus bNAbs were immunogenetically and structurally diverse, closely resembling human V3-glycan bNAbs. Env-bNAb coevolution revealed a diverse repertoire of bNAb precursors and the Env variants that matured them, yielding a molecular blueprint for vaccine design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS VaccinesBroadly Neutralizing Antibodiesenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesHIV InfectionsHIV-1Simian Immunodeficiency VirusVaccine DevelopmentAnimalsHumansEpitopesMacaca mulatta

Substanzen

AIDS VaccinesBroadly Neutralizing Antibodiesenv Gene Products, Human Immunodeficiency VirusEpitopesHIV Antibodies

Autor:innen und Institutionen

  • Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
  • Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • School of Biological Sciences, University of Southampton, Southampton, UK.
  • Duke Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA, USA.

ORCID-Profile: Ashwin N Skelly, Harry B Gristick, Hui Li, Edem Gavor, Andrew J Connell, Edward F Kreider, Lorie Marchitto, Michael P Hogarty, Maddy L Newby, Joel D Allen, Weimin Liu, Anthony P West, Kasirajan Ayyanathan, Rebecca A Osbaldeston, Macy J Akeley, Emily Lewis, Yingying Li, Ajay Singh, Kendra Cruickshank, Younghoon Park, Xuduo Li, Khaled Amereh, Elizabeth Van Itallie, John W Carey, Amie Albertus, Andrew T DeLaitsch, Jennifer R Keeffe, Daniel J Morris, Rumi Habib, Frederic Bibollet-Ruche, Nitesh Mishra, Gabriel Avillion, Samantha J Plante, Christian L Martella, Jinery Lora, Eric J D Wang, Mark G Lewis, Malcolm A Martin, Michel C Nussenzweig, Michael S Seaman, Darrell J Irvine, Kevin J Wiehe, Barton F Haynes, Kshitij Wagh, Bette Korber, Raiees Andrabi, Max Crispin, Drew Weissman, Pamela J Bjorkman, Beatrice H Hahn, George M Shaw

Förderung

  • NIAID NIH HHS
  • Bill & Melinda Gates Foundation
  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Bill and Melinda Gates Foundation

Zitieren

APA

Skelly, A. N., Gristick, H. B., Li, H., Gavor, E., Connell, A. J., Kreider, E. F., Marchitto, L., Hogarty, M. P., Newby, M. L., Allen, J. D., Liu, W., West, A. P., Ayyanathan, K., Campion, M. S., Winters, K., Gordon, C. G., Osbaldeston, R. A., Akeley, M. J., Lewis, E., …, & Shaw, G. M. (2026). Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design. Science, 392(6804). https://doi.org/10.1126/science.aec6396

Vancouver

Skelly AN, Gristick HB, Li H, Gavor E, Connell AJ, Kreider EF, et al. Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design. Science. 2026;392(6804). doi:10.1126/science.aec6396

BibTeX
@article{Skelly2026,
  author = {Skelly, Ashwin N and Gristick, Harry B and Li, Hui and Gavor, Edem and Connell, Andrew J and Kreider, Edward F and Marchitto, Lorie and Hogarty, Michael P and Newby, Maddy L and Allen, Joel D and Liu, Weimin and West, Anthony P and Ayyanathan, Kasirajan and Campion, Mary S and Winters, Kaitlyn and Gordon, Colette G and Osbaldeston, Rebecca A and Akeley, Macy J and Lewis, Emily and Li, Yingying and Singh, Ajay and Cruickshank, Kendra and Park, Younghoon and Zhao, Chengyan and Li, Xuduo and Amereh, Khaled and Van Itallie, Elizabeth and Carey, John W and Albertus, Amie and DeLaitsch, Andrew T and Keeffe, Jennifer R and Lituchy, Melinda G and Walsh, Agnes A and Morris, Daniel J and Habib, Rumi and Bibollet-Ruche, Frederic and Mishra, Nitesh and Avillion, Gabriel and Koranda, Nicholas S and Plante, Samantha J and Martella, Christian L and Lora, Jinery and Wang, Eric J D and Lewis, Mark G and Martin, Malcolm A and Nussenzweig, Michel C and Seaman, Michael S and Irvine, Darrell J and Wiehe, Kevin J and Haynes, Barton F and Wagh, Kshitij and Korber, Bette and Andrabi, Raiees and Crispin, Max and Weissman, Drew and Bjorkman, Pamela J and Hahn, Beatrice H and Shaw, George M},
  title = {Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6804},
  doi = {10.1126/science.aec6396}
}
Kostenlos starten →